A detailed history of Blue Chip Partners, Inc. transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Blue Chip Partners, Inc. holds 681 shares of DGX stock, worth $93,358. This represents 0.01% of its overall portfolio holdings.

Number of Shares
681
Holding current value
$93,358
% of portfolio
0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$137.09 - $137.09 $93,358 - $93,358
681 New
681 $93,000
Q4 2023

Feb 05, 2024

BUY
$120.62 - $141.12 $1,809 - $2,116
15 Added 0.56%
2,683 $369,000
Q3 2023

Oct 30, 2023

BUY
$121.86 - $144.92 $1,584 - $1,883
13 Added 0.49%
2,668 $325,000
Q2 2023

Aug 02, 2023

BUY
$130.56 - $146.84 $1,697 - $1,908
13 Added 0.49%
2,655 $373,000
Q1 2023

May 01, 2023

BUY
$131.53 - $155.76 $4,735 - $5,607
36 Added 1.38%
2,642 $373,000
Q4 2022

Feb 01, 2023

BUY
$123.31 - $157.26 $321,345 - $409,819
2,606 New
2,606 $407,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Blue Chip Partners, Inc. Portfolio

Follow Blue Chip Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Chip Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Blue Chip Partners, Inc. with notifications on news.